| Finding | Consider |
|---|---|
| QTc >500ms | TCA, antipsychotic, antihistamine, methadone |
| Wide QRS >120ms | TCA, flecainide — give NaHCO3 |
| Bradycardia/AV block | Beta-blocker, CCB, digoxin, organophosphate |
| Tall T waves | Digoxin toxicity pattern |
| Ventricular arrhythmia | TCA, cocaine — assess QTc |
Nursing: Give with antiemetic (ondansetron) — charcoal causes nausea. Document exact time given vs time of ingestion. Slurry via NGT if patient refuses. Black stools expected. Monitor for aspiration.
Body packer: Do NOT attempt forceful extraction. CT abdomen to count packets. Surgical team on standby. If packet ruptures: immediate life-threatening emergency.
Ipecac Syrup: NOT RECOMMENDED — no evidence of improved outcomes, delayed charcoal administration, aspiration risk, cardiac toxicity (emetine). Withdrawn from use in most countries.
Cathartics (sorbitol/magnesium sulphate): No evidence of clinical benefit. Associated with dehydration and electrolyte imbalance. Not recommended as routine adjunct.
King's College Criteria (liver transplant referral): Arterial pH <7.3 after resuscitation, OR all three of: INR >6.5 + creatinine >300 + grade III-IV encephalopathy.
| Route | Dose | Onset |
|---|---|---|
| IV | 0.4–2mg, repeat q2–3min | ~2 min |
| IM/SC | 0.4–0.8mg | ~5 min |
| Intranasal | 2mg (1mg per nostril) | ~8 min |
| Infusion | 2/3 effective dose/hr | Continuous |
Withdrawal precipitated by naloxone: agitation, tachycardia, vomiting, diaphoresis — supportive management. Withdrawal is rarely life-threatening but opioid toxicity is.
CONTRAINDICATIONS: Mixed overdose (TCA co-ingestion — seizure risk), chronic benzodiazepine users (withdrawal seizures), raised ICP, known seizure disorder. Most ED overdoses: flumazenil is NOT routinely used.
Staff PPE essential. Organophosphate absorbed dermally — remove patient's clothing, wash skin with soap and water. Avoid contaminating resuscitation room.
Avoid: physostigmine (seizures), flumazenil (seizure risk), fluids alone for hypotension. Seizure: benzodiazepine first-line. Avoid phenytoin (cardiac toxicity). Early intubation if deteriorating.
| COHb % | Symptoms |
|---|---|
| 10-20% | Headache, nausea, exertional dyspnoea |
| 20-40% | Severe headache, syncope, confusion |
| 40-60% | Seizures, coma, cardiopulmonary compromise |
| >60% | Fatal |
Pulse oximetry UNRELIABLE — reads COHb as OxyHb. Use co-oximetry ABG for true saturation.
| Level (mmol/L) | Action |
|---|---|
| 1.5–2.0 | Mild toxicity — monitoring, fluids |
| 2.0–2.5 | Moderate — IV fluids, WBI if SR tablets |
| >2.5 or symptomatic | Haemodialysis consideration |
Refusing NAC for paracetamol overdose: assess capacity; if lacking, treat. If patient has capacity, document refusal, explore reasons, contact psychiatry. Never abandon patient.
| Feature | Heat Stroke | Drug Hyperthermia |
|---|---|---|
| Context | Exertion, hot environment | Drug ingestion history |
| Sweating | Absent (classic) | Present (serotonin/sympathomimetic) |
| Skin | Hot, dry | Variable (anticholinergic: dry) |
| Neuromuscular | Absent clonus | Clonus/rigidity (serotonin/NMS) |
| CK | Elevated | Elevated (NMS, serotonin) |
Select a poisoning agent to view the specific antidote, dosing, monitoring, and key nursing actions.